Found: 7
Select item for more details and to access through your institution.
Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse Model.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00991
- By:
- Publication type:
- Article
Targeting the Mitochondria Metabolism of T-ALL with Novel Mitochondrial Complex I Inhibitor IACS-010759.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S1, doi. 10.1016/j.clml.2017.09.024
- By:
- Publication type:
- Article
Targeting MAPK Signaling Pathway with Cobimetinib (GDC-0973) Enhances Anti-Leukemia Efficacy of Venetoclax (ABT-199/GDC-0199) in Acute Myeloid Leukemia Models.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S282, doi. 10.1016/j.clml.2017.07.064
- By:
- Publication type:
- Article
Triple combination targeting methyltransferase, BCL‐2, and PD‐1 facilitates antileukemia responses in acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 531, doi. 10.1002/cncr.34566
- By:
- Publication type:
- Article
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30396-3
- By:
- Publication type:
- Article
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29669-8
- By:
- Publication type:
- Article
Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00369
- By:
- Publication type:
- Article